PECAM1 and carcinoma: In addition to existence of individual aneuploid CTCs and tumor CECs identified in carcinoma patients in this study, surprisingly, some aneuploid neoplastic cells and CTMs in cancer patients were found to have a non-reported, unique phenotype of CD31+/EpCAM+/Vimentin+.